|
1. |
Effects of a New Proglumide Analogue CR 1392 on Pancreatic Exocrine Secretion in the Rat |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 61-69
Makoto Otsuki,
Masatoshi Fujii,
Takahiko Nakamura,
Yoshinori Okabayashi,
Satoshi Tani,
Takashi Fujisawa,
Makoto Koide,
Shigeaki Baba,
Preview
|
PDF (1388KB)
|
|
摘要:
The effects of proglumide analogue. CR 1392, on pancreatic exocrine secretion were studied in the isolated pancreatic acini and the isolated perfused pancreata of rats. In the isolated acini, CR 1392 caused a parallel rightward shift of the dose-response curve for amylase secretion stimulated by cholecystokinin octapeptide (CCK-8). CR 1392 inhibited maximally stimulated amylase release by CCK-8 (100 pM) in a concentration-dependent manner, with a half maximal inhibition (ID50) at 8.0 ± 0.6 μM. CR 1409, another proglumide analogue, also caused a concentration-dependent inhibition (ID50: 3.2 ± 0.4 μM). Although CR 1409 was about 2.5-fold more potent than CR 1392 in inhibiting the stimulated amylase release, 1 mM CR 1409 caused 107.4 ± 0.9% increase in amylase release, suggesting acinar cell damage. CR 1392(1 mM) also caused 19.9 ± 2.3% increase in amylase release, but was less toxic than CR 1409. The antagonism produced by CR 1392 was selective for CCK and had no effect on amylase release stimulated by other receptor secretagogues or by agents bypassing receptors. CR 1392 added 20 min after the CCK-8 stimulation rapidly abolished pancreatic exocrine secretion in both isolated acini and isolated perfused pancreas. Although the inhibitory effect of CR 1392 was fully reversible in the isolated acini, the pancreata perfused with 100 μM CR 1392 for 20 min did not respond to the subsequent stimulation with CCK-8 for more than 20 min. These results indicate that CR 1392 is a potent, competitive, specific and long acting antagonist of CCK in rat pa
ISSN:0012-2823
DOI:10.1159/000199827
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
2. |
Oesophageal Function in Patients with Angina Pectoris: A Comparison of Patients with Normal Coronary Angiograms and Patients with Coronary Artery Disease |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 70-78
P.M. Schofield,
P.J. Whorwell,
N.H. Brooks,
D.H. Bennett,
P.E. Jones,
Preview
|
PDF (1336KB)
|
|
摘要:
Oesophageal function was assessed in 52 patients with angina pectoris whose coronary angiograms were completely normal and in 21 patients with angina pectoris who had significant coronary artery disease. During a standard oesophageal manometric study, abnormalities were found in 23 (44%) patients with normal coronary angiograms but in only 2 (10%) patients with coronary artery disease (p < 0.01). Twenty-four (46%) patients with normal coronary angiograms were found to have gastro-oesophageal reflux disease during 24-hour oesophageal pH monitoring. Of the 52 patients with normal coronary angiograms, 19 (37%) had gastro-oesophageal reflux disease and abnormal oesophageal motility, 5 (10%) had gastro-oesophageal reflux disease alone, and 7 (13%) had oesophageal motility disorder alone. The use of provocation procedures, including intravenous edrophonium during oesophageal manometry and treadmill exercise testing during pH monitoring, enabled the oesophageal abnormality to be demonstrated simultaneously with chest pain in 25 of these 31 patients. Typical angina pectoris, coincident with abnormal oesophageal motility, was precipitated in a subgroup of patients who had been shown to have oesophageal manometric abnormalities and gastro-oesophageal reflux disease by the infusion of hydrochloric acid into the oesophagus; both the chest pain and manometric abnormality resolved following the oral administration of antacid.
ISSN:0012-2823
DOI:10.1159/000199828
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
3. |
A Multicenter, Randomized, Double-Blind Study Comparing a Daily Bedtime Administration of Famotidine and Ranitidine in Short-Term Treatment of Active Duodenal Ulcer |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 79-85
R. Alcalá-Santaella,
J. Guardia,
J. Pajares,
J. Piqué,
L. Pita,
E. Alvárez,
P. Castellanos,
L. Guarner,
J. Ortiz,
R. Pesquera,
V. Vargas,
R. Ruiz-Capellán,
Preview
|
PDF (981KB)
|
|
摘要:
The efficacy and safety of famotidine and ranitidine in the treatment of active duodenal ulcer were compared in a multicenter, randomized double-blind study. The study was carried out in 5 centers which included a total of 143 patients with endoscopically documented active duodenal ulcer. The patients received either famotidine (1 tablet of 40 mg at night) or ranitidine (2 tablets of 150 mg at night). Endoscopic examinations were performed at 4 and 6 weeks of active treatment. Day and nocturnal pain were also monitored and the laboratory and clinical profiles evaluated. One hundred and thirty-three patients fulfilled the evaluation criteria (66 patients in the famotidine group and 67 in the ranitidine group). Healing rates at weeks 4 or 6 of treatment showed no significant differences between the famotidine and the ranitidine groups. The healing rates were 79% at week 4 and 96% at week 6 in the famotidine group, and 77% at week 4 and 95% at week 6 in the ranitidine group. Similar results were observed in both treatment groups with regard to pain resolution, decrease in antacid intake and safety profile.
ISSN:0012-2823
DOI:10.1159/000199829
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
4. |
A Multicenter, Randomized, Double-Blind Study Comparing Famotidine with Cimetidine in the Treatment of Active Duodenal Ulcer Disease |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 86-92
L. Rodrigo,
J. Viver,
F. Conchillo,
E. Barrio,
M. Forné,
J.M. Zozaya,
A. Alvarez,
P. Dieguez,
M. Muñoz,
J. Panés,
J. Jiménez,
R. Ruiz-Capellán,
Preview
|
PDF (990KB)
|
|
摘要:
The efficacy and safety of famotidine (40 mg at night), a new potent H2-receptor antagonist, has been studied in 119 patients by four investigators in four Spanish hospitals in a randomized double-blind comparative study with cimetidine (800 mg at night). Antacid tablets were allowed as additional treatment, if needed for pain relief. There were no significant differences between the groups in baseline characteristics, including duodenal ulcer size. Efficacy parameters included daytime and nocturnal symptom relief and duodenal ulcer healing, documented by endoscopy, and defined as complete reepithelization of the ulcer crater. Endoscopy was performed at baseline and after 4 and 6 weeks of treatment. One hundred and five patients fulfilled the evaluation criteria (51 patients in the famotidine group and 54 in the cimetidine group). After 4 weeks, in 91.6% of the patients receiving famotidine and 82.3% of the patients receiving cimetidine ulcers were healed. After 6 weeks, healing rates were 96% (famotidine) and 85.1% (cimetidine) (p = 0.056). Pain relief was rapid in both treatment groups, with a tendency to better response during the day in the famotidine group. The intake of antacids, as well as the clinical and laboratory safety profile were similar for both groups.
ISSN:0012-2823
DOI:10.1159/000199830
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
5. |
Mild Pancreatic Damage in Acute Viral Hepatitis |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 93-97
Domenico Taranto,
Alfredo Carrato,
Marco Romano,
Giuseppe Maio,
Crescenzo M. Izzo,
Camillo Del Vecchio Blanco,
Preview
|
PDF (711KB)
|
|
摘要:
Whether and to what extent the pancreas is involved in acute viral hepatitis is still unclear. In order to address this issue we evaluated serum and urinary amylase and isoamylase levels in 92 patients with acute viral hepatitis of different etiology and in 60 healthy volunteers. Furthermore, pancreatic structure and volume were evaluated by ultrasound scanning. Significant increase in serum and urinary pancreatic isoamylases was found in 12 and 35% of patients, respectively, in the early stage of the disease. Increase in serum pancreatic isoamylases was found only in patients suffering from B and non-A, non-B hepatitis. Ultrasonographic evaluation did not show any change in pancreatic structure and volume. In conclusion, this study suggests that mild pancreatic damage may occur during viral hepatitis.
ISSN:0012-2823
DOI:10.1159/000199831
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
6. |
Pulmonary Permeability in Coeliac Disease and Inflammatory Bowel Disease |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 98-103
D.A.F. Robertson,
N. Taylor,
H. Sidhu,
A. Britten,
C.L. Smith,
G. Holdstock,
Preview
|
PDF (845KB)
|
|
摘要:
Respiratory disease and subclinical pulmonary abnormalities are recognised complications of both coeliac disease (CD) and inflammatory bowel disease (IBD) but the pathogenesis of the lung disease remains uncertain. We have studied lung function, including permeability measured by clearance of inhaled technetium-99m diethylene triamine pentacetic acid in 25 patients with IBD, 18 patients with CD on a gluten-free diet, and in 20 normal controls, all without respiratory symptoms. In IBD there was evidence of obstruction to airflow (mean forced expiratory volume in 1 s/forced vital capacity equals 75.8%, control 81 %; p < 0.05) but no change in pulmonary permeability (half-time clearance equals 70.3 vs. 69.2 min). In CD airflow was not significantly different from control (forced expiratory volume in 1 s/forced vital capacity equals 80%) but there was an increase in pulmonary permeability (half-time clearance equals 48.9 min; p < 0.01). These findings suggest that the mechanisms of lung disease in CD differs from that in IBD and supports the hypothesis of a common mucosal defect in lung and small intestine in CD allowing increased permeability.
ISSN:0012-2823
DOI:10.1159/000199832
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
7. |
Intestinal Permeability to51Cr-Labelled Ethylenediaminetetraacetate in Food-Intolerant Subjects |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 104-109
Glenis Scadding,
Ingvar Bjarnason,
Jonathan Brostoff,
Jonathan Levi,
Timothy J. Peters,
Preview
|
PDF (755KB)
|
|
摘要:
Intestinal permeation of 51Cr-labelled ethylenediaminetetraacetate (51Cr-EDTA) was normal in 8 food-intolerant patients. Following ingestion of the offending food stuff there was a significant (p < 0.003) decrease in the permeation of 51Cr-EDTA but the same phenomenon was observed in control subjects (n = 5) following cereal. Eight patients were tested following ingestion of lentil puree and subsequently with lentil puree containing the food to which they were sensitive. In these patients there was a significant increase in the permeation of 51Cr-EDTA following the 2nd test (p < 0.01), but this was of insufficient magnitude to be of diagnostic use. These results show that food intolerance does involve some, but not gross changes in intestinal permeability to 51Cr-EDTA.
ISSN:0012-2823
DOI:10.1159/000199833
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
8. |
Clinical Features, Course, Viral Markers and Follow-Up in Young versus Adult Nonalcoholic Cirrhotics A Retrospective Study |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 110-115
H. Qureshi,
S.J. Zuberi,
T.Z. Lodi,
E. Alam,
Preview
|
PDF (746KB)
|
|
摘要:
To determine the presenting features and prognosis of nonalcoholic cirrhosis, retrospective analysis was done in 145 cases. Of the total, 48 patients (33%) belonged to the young (≤ 35 years), and 97 (67%) to the adult age group ( > 35 years) with no predominance of either sex. The etiology of cirrhosis and the positivity of viral markers were similar in both groups. Adults had on presentation a higher frequency of anorexia while hematemesis was more frequent in the young group (p < 0.001). During a mean follow-up ( ± SE) of 31.7 ± 5.5 and 16.3 ± 2.2 months in the young and adult group, respectively, 68 and 63% cases survived 5 years. Liver failure (53.8 and 44.4%) and variceal bleeding (23 and 11.1%) were the main causes of death in both groups, accounting for 27% mortality in each g
ISSN:0012-2823
DOI:10.1159/000199834
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
9. |
Octreotide (SMS 201-995) in the Treatment of Metastatic Glucagonoma: Report of One Case and Review of the Literature |
|
Digestion,
Volume 42,
Issue 2,
1989,
Page 116-120
A. Rosenbaum,
B. Flourie,
S. Chagnon,
M. Blery,
R. Modigliani,
Preview
|
PDF (624KB)
|
|
摘要:
We report 1 patient with a necrolytic migratory erythema, a high plasma glucagon concentration and a metastatic pancreatic endocrine tumor who has now been treated effectively for 33 months with the somatostatin analogue octreotide (SMS 201–995) (400 μg/day). The results of SMS 201–995 in the treatment of glucagonoma syndrome are revi
ISSN:0012-2823
DOI:10.1159/000199835
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
|